The FDA approved changes to the labels for six menopausal hormone therapy products in a move the agency said clarifies risk considerations for the drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results